In observance of World Cancer Day 2026, the Istituto Superiore di Sanità (ISS) emphasized personalized oncology as a transformative approach in cancer treatment. Led by Director Mauro Biffoni, the ISS’s Department of Molecular Oncology highlighted research focused on targeted therapies tailored to individual tumors. The institution conducts preclinical studies to identify new therapeutic targets and collaborates on clinical trials with over 40 oncology centers. Biffoni noted participation in an Italian study verifying the efficacy of molecular-targeted therapies compared to standard treatments. The ISS also aligned with the 2026 World Cancer Day theme, ‘Uniti nell’unicità’ (United in Uniqueness), underscoring the importance of patient-centered care that respects individual medical and personal narratives.
Source: Istituto Superiore di Sanità (ISS).
Information reproduced from www.iss.it.
No endorsement by ISS is implied.
https://www.iss.it/-/al-singolo-tumore-la-sua-cura-l-oncologia-personalizzata-%C3%A8-la-nuova-frontiera-delle-cure-1
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.